What cereneo Foundation does

cereneo Foundation is a privately held, for-profit entity incorporated in 2017 and headquartered in Vitznau, Switzerland, with a workforce of 11-50 employees. According to its firmographic profile, the company develops and validates a biomechanical assessment and therapy platform focused on dexterity and finger individuation — a niche within clinical neurorehabilitation that targets the restoration and measurement of fine motor control, most plausibly in stroke recovery, spinal cord injury, or similar motor-impairment populations. The platform is positioned around objective biomechanical measurement of hand and finger function rather than purely subjective clinical scoring, implying instrumented assessment hardware, motion-capture or sensor-based measurement, and a therapy delivery or training component.

The underlying technology is described in platform terms (assessment plus therapy), suggesting an integrated system that both quantifies impairment and prescribes or delivers intervention, with validation as a stated activity — a signal that the company operates in a research-grade or clinically regulated environment where evidence generation matters to adoption. Its Swiss domicile and small employee count indicate a tightly scoped organization likely anchored to a single clinical site or research partner rather than a broad commercial sales motion.

The business model is not disclosed in the source material: no pricing models, revenue mechanics, go-to-market motion, named customers, or customer segments are present. The legal name "cereneo Foundation" combined with the for-profit classification is internally inconsistent with standard Swiss corporate terminology and suggests either a non-standard governance form, a hybrid research/commercial entity, or a data-quality artifact. Revenue, funding history, partnerships, and management team data are likewise absent from the inputs, so the commercial mechanics of the business cannot be characterized with confidence beyond the structural facts above.

Name

cereneo Foundation

Website

https://www.cereneo.foundation

Company type

Private

Founded year

2017

Headcount range

11–50 employees

Short description

cereneo Foundation is a privately held Swiss for-profit company (founded 2017, Vitznau) that develops and validates a biomechanical assessment and therapy platform for dexterity and finger individuation, serving the clinical neurorehabilitation market with 11-50 employees.

Ownership category

akta.pro rank

Product category

Rehabilitation Technology

NAICS

Vocational Rehabilitation Services (62431)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Neurorehabilitation Centers (HLAFAFAH)

akta.pro secondary industries

Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)

Keywords

• Biomechanical assessment platform
• Dexterity rehabilitation therapy
• Finger individuation technology
• Neurorehabilitation platform
• Motor function assessment

Headquarters

HQ city

Vitznau

HQ country

Switzerland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations

Core offering

cereneo Foundation develops and validates a biomechanical assessment and therapy platform that measures and trains dexterity and finger individuation. The platform is intended to support clinical and research-grade evaluation of fine motor function in rehabilitation contexts. It is aimed at clinicians and researchers working in motor rehabilitation and neuromotor recovery.

Differentiator

Problem solved

Functional benefit

Products and services

• Biomechanical Assessment and Therapy Platform for Dexterity and Finger Individuation A biomechanical platform that measures and trains dexterity and finger individuation, designed for clinicians and researchers in neurorehabilitation and motor recovery.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Hocoma: Swiss-based developer of robotic and sensor-based rehabilitation devices for neurorehabilitation, including upper-limb therapy. Directly comparable as a clinical-grade assessment-and-therapy platform serving neurologic rehab populations.
• Tyromotion: Austria-based provider of robotic and digital therapy devices for upper and lower extremity rehabilitation. Closely overlaps with cereneo Foundation on neurorehab therapy platforms targeting functional recovery.
• Saebo: US company specialising in hand, arm, and finger rehabilitation devices and orthoses for stroke and neurological injury. Directly comparable on the dexterity/finger individuation use case cereneo Foundation targets.
• Neofect: Developer of smart rehabilitation devices and software for hand, arm, and lower limb recovery. Comparable biomechanical assessment and therapy platform model for neurologic and orthopaedic patients.

Broad incumbents

• Fourier Intelligence: Shanghai-based rehabilitation robotics company with a broad upper- and lower-limb portfolio. Larger incumbent with overlapping technology in robotic therapy platforms used in neurorehabilitation clinics.
• Ekso Bionics: Developer of exoskeleton and robotic rehabilitation devices primarily for gait and lower-limb recovery. Adjacent incumbent in robotic neurorehabilitation with shared clinical-customer base.
• MindMaze: Swiss-based digital neurotherapy company combining VR, motion capture, and assessment tools for neurologic recovery. Closest peer by geography and clinical category, though operating at much broader scope.

Emerging players

• Bionik Laboratories: Public-listed developer of robotic upper-limb rehabilitation devices and data-driven therapy tools. Comparable in biomechanical upper-limb therapy for stroke patients.
• Rehab-Robotics: Hong Kong-based developer of robotic hand rehabilitation devices (Hand of Hope). Direct overlap on the hand/finger rehabilitation use case and similar target customers.
• Kinova: Canadian robotics company whose assistive and rehabilitation-grade robotic arms are used in clinical therapy contexts. Comparable as a supplier of biomechanical platforms enabling therapeutic assessment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/cereneo-foundation

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about cereneo Foundation